These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 28950052)

  • 21. Pigmentary Markers in Danes--Associations with Quantitative Skin Colour, Nevi Count, Familial Atypical Multiple-Mole, and Melanoma Syndrome.
    Johansen P; Andersen JD; Madsen LN; Ullum H; Glud M; Børsting C; Gniadecki R; Morling N
    PLoS One; 2016; 11(3):e0150381. PubMed ID: 26938746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Main pigmentary features and melanocortin 1 receptor (MC1R) gene polymorphisms in the population of the Canary Islands.
    de-Misa RF; Pérez-Méndez LI; Hernández-Jiménez JG; Rodríguez Mdel C; Vilar MC; Suárez J; Claveríe-Martín F
    Int J Dermatol; 2008 Aug; 47(8):806-11. PubMed ID: 18717860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variations of the melanocortin-1 receptor and the glutathione-S transferase T1 and M1 genes in cutaneous malignant melanoma.
    Mössner R; Anders N; König IR; Krüger U; Schmidt D; Berking C; Ziegler A; Brockmöller J; Kaiser R; Volkenandt M; Westphal GA; Reich K
    Arch Dermatol Res; 2007 Jan; 298(8):371-9. PubMed ID: 17072629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Common genetic variants associated with melanoma risk or naevus count in patients with wildtype MC1R melanoma.
    Calbet-Llopart N; Combalia M; Kiroglu A; Potrony M; Tell-Martí G; Combalia A; Brugues A; Podlipnik S; Carrera C; Puig S; Malvehy J; Puig-Butillé JA
    Br J Dermatol; 2022 Nov; 187(5):753-764. PubMed ID: 35701387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of dermoscopic features for distinguishing melanoma from special site nevi of the breast.
    Merkel EA; Martini MC; Amin SM; Lee CY; Gerami P
    J Am Acad Dermatol; 2016 Aug; 75(2):364-70. PubMed ID: 27313053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interactive effects of MC1R and OCA2 on melanoma risk phenotypes.
    Duffy DL; Box NF; Chen W; Palmer JS; Montgomery GW; James MR; Hayward NK; Martin NG; Sturm RA
    Hum Mol Genet; 2004 Feb; 13(4):447-61. PubMed ID: 14709592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MC1R variants increase risk of melanomas harboring BRAF mutations.
    Fargnoli MC; Pike K; Pfeiffer RM; Tsang S; Rozenblum E; Munroe DJ; Golubeva Y; Calista D; Seidenari S; Massi D; Carli P; Bauer J; Elder DE; Bastian BC; Peris K; Landi MT
    J Invest Dermatol; 2008 Oct; 128(10):2485-90. PubMed ID: 18368129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Melanocortin 1 receptor and its influence on naevi and melanoma in dark-skinned phenotypes.
    Smith DJM
    Australas J Dermatol; 2019 Aug; 60(3):192-199. PubMed ID: 30585306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dermoscopy, reflectance confocal microscopy and histopathology of an amelanotic melanoma from an individual heterozygous for MC1R and tyrosinase variant alleles.
    Curchin C; Wurm E; Jagirdar K; Sturm R; Soyer P
    Australas J Dermatol; 2012 Nov; 53(4):291-4. PubMed ID: 22497519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Germline melanocortin-1-receptor genotype is associated with severity of cutaneous phenotype in congenital melanocytic nevi: a role for MC1R in human fetal development.
    Kinsler VA; Abu-Amero S; Budd P; Jackson IJ; Ring SM; Northstone K; Atherton DJ; Bulstrode NW; Stanier P; Hennekam RC; Sebire NJ; Moore GE; Healy E
    J Invest Dermatol; 2012 Aug; 132(8):2026-32. PubMed ID: 22572819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Melanocortin 1 receptor function: shifting gears from determining skin and nevus phenotype to fetal growth.
    Gruis NA; van Doorn R
    J Invest Dermatol; 2012 Aug; 132(8):1953-5. PubMed ID: 22797298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sporadic melanoma in South-Eastern Italy: the impact of melanocortin 1 receptor (MC1R) polymorphism analysis in low-risk people and report of three novel variants.
    Guida S; Bartolomeo N; Zanna PT; Grieco C; Maida I; De Summa S; Tommasi S; Guida M; Azzariti A; Foti C; Filotico R; Guida G
    Arch Dermatol Res; 2015 Aug; 307(6):495-503. PubMed ID: 25736238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Morphologic changes of acquired melanocytic nevi with eccentric foci of hyperpigmentation ("Bolognia sign") assessed by dermoscopy.
    Pizzichetta MA; Massone C; Grandi G; Pelizzo G; Soyer HP
    Arch Dermatol; 2006 Apr; 142(4):479-83. PubMed ID: 16618868
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical characteristics of patients with cutaneous melanoma according to variants in the melanocortin 1 receptor gene.
    Peña-Vilabelda MM; García-Casado Z; Requena C; Traves V; López-Guerrero JA; Guillén C; Kumar R; Nagore E
    Actas Dermosifiliogr; 2014 Mar; 105(2):159-71. PubMed ID: 24238329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MC1R variation and melanoma risk in relation to host/clinical and environmental factors in CDKN2A positive and negative melanoma patients.
    Ghiorzo P; Bonelli L; Pastorino L; Bruno W; Barile M; Andreotti V; Nasti S; Battistuzzi L; Grosso M; Bianchi-Scarrà G; Queirolo P
    Exp Dermatol; 2012 Sep; 21(9):718-20. PubMed ID: 22804906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Melanocortin-1 receptor (MC1R) gene variants and dysplastic nevi modify penetrance of CDKN2A mutations in French melanoma-prone pedigrees.
    Chaudru V; Laud K; Avril MF; Minière A; Chompret A; Bressac-de Paillerets B; Demenais F
    Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2384-90. PubMed ID: 16214921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The melanocortin-1 receptor gene polymorphism and association with human skin cancer.
    Beaumont KA; Liu YY; Sturm RA
    Prog Mol Biol Transl Sci; 2009; 88():85-153. PubMed ID: 20374726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MC1R genotypes and risk of melanoma before age 40 years: a population-based case-control-family study.
    Cust AE; Goumas C; Holland EA; Agha-Hamilton C; Aitken JF; Armstrong BK; Giles GG; Kefford RF; Schmid H; Hopper JL; Mann GJ; Jenkins MA
    Int J Cancer; 2012 Aug; 131(3):E269-81. PubMed ID: 22095472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MC1R variants, melanoma and red hair color phenotype: a meta-analysis.
    Raimondi S; Sera F; Gandini S; Iodice S; Caini S; Maisonneuve P; Fargnoli MC
    Int J Cancer; 2008 Jun; 122(12):2753-60. PubMed ID: 18366057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of polymorphic variants in the melanocortin-1 receptor gene with cutaneous pigmentation using an evolutionary approach.
    Kanetsky PA; Ge F; Najarian D; Swoyer J; Panossian S; Schuchter L; Holmes R; Guerry D; Rebbeck TR
    Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):808-19. PubMed ID: 15159314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.